Literature DB >> 8581015

The glycoprotein of viral hemorrhagic septicemia virus (VHSV): antigenicity and role in virulence.

M Béarzotti1, A F Monnier, P Vende, J Grosclaude, P de Kinkelin, A Benmansour.   

Abstract

In order to study the antigenic structure of the G protein of VHSV, we produced several anti-G monoclonal antibodies (MAbs) and used 4 neutralizing MAbs (NMAbs) to select resistant (MAR) mutants. Each MAR mutant was confronted with the 4 NMAbs in a neutralization test, and also with our panel of MAbs in surface plasmon resonance (SPR) analysis to determine the extent of their relatedness. Determination of the sequence of the entire G gene of representative MAR mutants allowed us to map the mutations responsible for the resistant phenotypes. We identified several locations on the G protein sequence, which represent, most probably, critical positions within the binding sites of the neutralizing MAbs. In addition, the MAR mutants selected with a cross-reactive MAb exhibited a reduced pathogenicity for fish. This indicated that the regions bearing the point mutations selected with MAb C10 were probably involved in the determination of the virulent phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581015

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  17 in total

1.  Pepscan mapping of viral hemorrhagic septicemia virus glycoprotein G major lineal determinants implicated in triggering host cell antiviral responses mediated by type I interferon.

Authors:  V Chico; A Martinez-Lopez; M Ortega-Villaizan; A Falco; L Perez; J M Coll; A Estepa
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Heterologous exchanges of the glycoprotein and the matrix protein in a Novirhabdovirus.

Authors:  Stéphane Biacchesi; Monique Béarzotti; Edwige Bouguyon; Michel Brémont
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Reversible inhibition of spreading of in vitro infection and imbalance of viral protein accumulation at low pH in viral hemorrhagic septicemia rhabdovirus, a salmonid rhabdovirus.

Authors:  V Mas; A Rocha; L Perez; J M Coll; A Estepa
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Conformation- and fusion-defective mutations in the hypothetical phospholipid-binding and fusion peptides of viral hemorrhagic septicemia salmonid rhabdovirus protein G.

Authors:  A Rocha; S Ruiz; C Tafalla; J M Coll
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Characterization of intramolecular disulfide bonds and secondary modifications of the glycoprotein from viral hemorrhagic septicemia virus, a fish rhabdovirus.

Authors:  K Einer-Jensen; T N Krogh; P Roepstorff; N Lorenzen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  Introduction of Viral Hemorrhagic Septicemia Virus into Freshwater Cultured Rainbow Trout Is Followed by Bursts of Adaptive Evolution.

Authors:  Anna A Schönherz; Roald Forsberg; Bernt Guldbrandtsen; Albert J Buitenhuis; Katja Einer-Jensen
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

7.  Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae.

Authors:  Paloma Encinas; Silvia Gomez-Sebastian; Maria Carmen Nunez; Eduardo Gomez-Casado; Jose M Escribano; Amparo Estepa; Julio Coll
Journal:  BMC Res Notes       Date:  2011-06-21

8.  Can VHS Virus Bypass the Protective Immunity Induced by DNA Vaccination in Rainbow Trout?

Authors:  Dagoberto Sepúlveda; Niels Lorenzen
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

9.  Molecular characterization of the Great Lakes viral hemorrhagic septicemia virus (VHSV) isolate from USA.

Authors:  Arun Ammayappan; Vikram N Vakharia
Journal:  Virol J       Date:  2009-10-25       Impact factor: 4.099

10.  Molecular characterization of the virulent infectious hematopoietic necrosis virus (IHNV) strain 220-90.

Authors:  Arun Ammayappan; Scott E LaPatra; Vikram N Vakharia
Journal:  Virol J       Date:  2010-01-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.